Enable new Parkinson treatment development
- Trial ID
- NCT06203106
- Official Title
- NYSCF Scientific Discovery Biobank
- Goal
- Enable new Parkinson treatment development
- Status
- RECRUITING
- Sponsor
- New York Stem Cell Foundation Research Institute
- Study Type
- OBSERVATIONAL
- Enrollment
- 10000 participants
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, Alzheimer Disease, Alzheimer Disease, Early Onset, Alzheimer Disease, Late Onset, Batten Disease, Corticobasal Degeneration, Dementia, Frontotemporal Dementia, Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, INAD, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Macular Degeneration, Ovarian Cancer, Cervical Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, PTSD, Post Traumatic Stress Disorder
- Interventions
- Biological Sample Collection
Plain-Language Summary
The goal is to build a large, shared biobank of blood, saliva, skin, and transferred samples linked to medical data so researchers can speed up discovery of biomarkers and new treatments for Parkinson's and many other neurological and medical conditions. Participants provide samples that can be used to extract DNA, measure proteins, create induced pluripotent stem cell lines, and run lab studies to understand disease mechanisms or test experimental therapies. The study is open to people 30 days and older who have Parkinson's disease or other listed conditions, or who are healthy controls, with adults providing consent and people without decisional capacity allowed with assent plus a legally authorized representative consent. People who are wards of the state, who have certain bleeding or skin-healing problems relevant to sample collection, or who have AIDS with CD4 under 200 are excluded.
Locations
- New York Stem Cell Foundation Research Institute, New York, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Biological Sample Collection. The goal is to build a large, shared biobank of blood, saliva, skin, and transferred samples linked to medical data so researchers can speed up discovery of biomarkers and new treatments for Parkinson's and many other neurological and medical conditions. Participants provide samples that can be used to extract DNA, measure proteins, create induced pluripotent stem cell lines, and run lab studies to understand disease mechanisms or test experimental therapies. The study is open to people 30 days and older who have Parkinson's disease or other listed conditions, or who are healthy controls, with adults providing consent and people without decisional capacity allowed with assent plus a legally authorized representative consent. People who are wards of the state, who have certain bleeding or skin-healing problems relevant to sample collection, or who have AIDS with CD4 under 200 are excluded.
- Who can participate?
- Participants must be at least 30 Days.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 23 years.